OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical features of Japanese children and adolescents with systemic lupus erythematosus: Results of 1980-1994 survey.
Published in:
Pediatrics International, 1997, v. 39, n. 2, p. 250, doi. 10.1111/j.1442-200X.1997.tb03594.x
By:
- TAKEI, SYUJI;
- MAENO, NOBUAKI;
- SHIGEMORI, MASAHIKO;
- IMANAKA, HIROYUKI;
- MORI, HIROSUMI;
- NEROME, YASUHITO;
- KANEKURA, SYOKO;
- TAKEZAKI, TOMOKO;
- HOKONOHARA, MASASHI;
- MIYATA, KOICHIRO;
- FUJIKAWA, SATOSHI
Publication type:
Article
S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.
Published in:
Clinical Rheumatology, 2019, v. 38, n. 3, p. 835, doi. 10.1007/s10067-018-4359-9
By:
- Yamasaki, Yuichi;
- Takei, Syuji;
- Imanaka, Hiroyuki;
- Kubota, Tomohiro;
- Nonaka, Yukiko;
- Takezaki, Tomoko;
- Kawano, Yoshifumi
Publication type:
Article
Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.
Published in:
2017
By:
- TOMOKAZU NAGAKURA;
- HIROYUKI WAKIGUCHI;
- TOMOHIRO KUBOTA;
- TSUYOSHI YAMATOU;
- YUICHI YAMASAKI;
- YUKIKO NONAKA;
- YASUHITO NEROME;
- HARUMI AKAIKE;
- TOMOKO TAKEZAKI;
- HIROYUKI IMANAKA;
- YOSHIFUMI KAWANO;
- SYUJI TAKEI;
- Nagakura, Tomokazu;
- Wakiguchi, Hiroyuki;
- Kubota, Tomohiro;
- Yamatou, Tsuyoshi;
- Yamasaki, Yuichi;
- Nonaka, Yukiko;
- Nerome, Yasuhito;
- Akaike, Harumi
Publication type:
Letter
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor.
Published in:
Modern Rheumatology, 2016, v. 26, n. 4, p. 551, doi. 10.3109/14397595.2015.1109784
By:
- Yuichi Yamasaki;
- Syuji Takei;
- Hiroyuki Imanaka;
- Yasuhito Nerome;
- Tomohiro Kubota;
- Yukiko Nonaka;
- Harumi Akaike;
- Tomoko Takezaki;
- Yoshifumi Kawano
Publication type:
Article
The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment.
Published in:
Modern Rheumatology, 2016, v. 26, n. 3, p. 368, doi. 10.3109/14397595.2015.1085608
By:
- Yasuhito Nerome;
- Harumi Akaike;
- Yukiko Nonaka;
- Tomoko Takezaki;
- Tomohiro Kubota;
- Tsuyoshi Yamato;
- Yuichi Yamasaki;
- Hiroyuki Imanaka;
- Yoshifumi Kawano;
- Syuji Takei
Publication type:
Article
Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis.
Published in:
Modern Rheumatology, 2016, v. 26, n. 3, p. 358, doi. 10.3109/14397595.2015.1083147
By:
- Tomohiro Kubota;
- Hiroyuki Imanaka;
- Syuji Takei;
- Tsuyoshi Yamatou;
- Yasuhito Nerome;
- Yuuichi Yamasaki;
- Yukiko Nonaka;
- Harumi Akaike;
- Tomoko Takezaki;
- Yosihumi Kawano
Publication type:
Article
A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.
Published in:
Modern Rheumatology, 2008, v. 18, n. 2, p. 189, doi. 10.3109/s10165-008-0024-5
By:
- Nerome, Yasuhito;
- Imanaka, Hiroyuki;
- Nonaka, Yukiko;
- Tsuru, Yumiko;
- Maeno, Nobuaki;
- Takezaki, Tomoko;
- Mori, Hirosumi;
- Akaike, Harumi;
- Kubota, Tomohiro;
- Kawano, Yoshifumi;
- Takei, Syuji
Publication type:
Article

Found: 7

Clinical features of Japanese children and adolescents with systemic lupus erythematosus: Results of 1980-1994 survey.

S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.

Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.

Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor.

The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment.

Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis.

A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.